Mather Group, Llc. Athira Pharma, Inc. Transaction History
Mather Group, Llc.
- $9.81 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding ATHA
# of Institutions
11Shares Held
1.34MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY676KShares$3.12 Million0.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ425KShares$1.96 Million0.01% of portfolio
-
Potomac Capital Management, Inc.150KShares$689,5860.64% of portfolio
-
Invst, LLC Indianapolis, IN45KShares$207,4500.0% of portfolio
-
Rothschild Investment Corp33.6KShares$154,8960.01% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $174M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...